ARTICLE | Company News
Pieris, Syngenta anticalin deal
April 14, 2005 1:19 AM UTC
Pieris Proteolab (Freising, Germany) and Syngenta (SWX:SYNN; SYT) partnered to develop an anticalin-based compound for an undisclosed indication. Anticalins are engineered proteins with antibody-like ...